Deregulation of the PI3K/AKT pathway by the inactivation of PTEN, was found in 55 % of GCB-DLBCL cases, but only in 14 % of non-GCB-DLBCL and worsens prognosis [8]. The gene discussed is PIK3CA; the disease is diffuse large B-cell lymphoma.